Skip to main content

Response to Timothé Ménard.

Publication ,  Journal Article
Movaghar, A; Page, D; Brilliant, M; Mailick, M
Published in: Genet Med
March 2022

Duke Scholars

Published In

Genet Med

DOI

EISSN

1530-0366

Publication Date

March 2022

Volume

24

Issue

3

Start / End Page

752 / 753

Location

United States

Related Subject Headings

  • Genetics & Heredity
  • 3105 Genetics
  • 1103 Clinical Sciences
  • 0604 Genetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Movaghar, A., Page, D., Brilliant, M., & Mailick, M. (2022). Response to Timothé Ménard. Genet Med, 24(3), 752–753. https://doi.org/10.1016/j.gim.2021.10.023
Movaghar, Arezoo, David Page, Murray Brilliant, and Marsha Mailick. “Response to Timothé Ménard.Genet Med 24, no. 3 (March 2022): 752–53. https://doi.org/10.1016/j.gim.2021.10.023.
Movaghar A, Page D, Brilliant M, Mailick M. Response to Timothé Ménard. Genet Med. 2022 Mar;24(3):752–3.
Movaghar, Arezoo, et al. “Response to Timothé Ménard.Genet Med, vol. 24, no. 3, Mar. 2022, pp. 752–53. Pubmed, doi:10.1016/j.gim.2021.10.023.
Movaghar A, Page D, Brilliant M, Mailick M. Response to Timothé Ménard. Genet Med. 2022 Mar;24(3):752–753.

Published In

Genet Med

DOI

EISSN

1530-0366

Publication Date

March 2022

Volume

24

Issue

3

Start / End Page

752 / 753

Location

United States

Related Subject Headings

  • Genetics & Heredity
  • 3105 Genetics
  • 1103 Clinical Sciences
  • 0604 Genetics